Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Atsushi Kumanogoh »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Atsushi Komatsuda < Atsushi Kumanogoh < Atsushi Mizuta  Facettes :

List of bibliographic references indexed by Atsushi Kumanogoh

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000432 (2020) Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon]Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
000D54 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-
000D55 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
000E22 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
001376 (2018) Michihito Katayama [Japon] ; Kaori Ota [Japon] ; Noriko Nagi-Miura [Japon] ; Naohito Ohno [Japon] ; Norikazu Yabuta [Japon] ; Hiroshi Nojima [Japon] ; Atsushi Kumanogoh [Japon] ; Toru Hirano [Japon]Ficolin-1 is a promising therapeutic target for autoimmune diseases
001414 (2018) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
001A11 (2016) Takayoshi Morita [Japon] ; Yoshihito Shima [Japon] ; James Badger Wing [Japon] ; Shimon Sakaguchi [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
002026 (2015) Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
002677 (2013) Yoshikazu Nakaoka ; Kaori Higuchi ; Yoh Arita ; Michio Otsuki ; Kaori Yamamoto ; Takahiro Hashimoto-Kataoka ; Taku Yasui ; Kuniyasu Ikeoka ; Tomohito Ohtani ; Yasushi Sakata ; Yoshihito Shima ; Atsushi Kumanogoh ; Keiko Yamauchi-Takihara ; Toshio Tanaka ; Tadamitsu Kishimoto ; Issei KomuroTocilizumab for the treatment of patients with refractory Takayasu arteritis.
002770 (2013) Haruhiko Hirata ; Satoshi Tetsumoto ; Takashi Kijima ; Hiroshi Kida ; Toru Kumagai ; Ryo Takahashi ; Yasushi Otani ; Koji Inoue ; Hanako Kuhara ; Kazuki Shimada ; Izumi Nagatomo ; Yoshito Takeda ; Sho Goya ; Kazuyuki Yoshizaki ; Ichiro Kawase ; Isao Tachibana ; Tadamitsu Kishimoto ; Atsushi KumanogohFavorable responses to tocilizumab in two patients with cancer-related cachexia.
003471 (2012) Atsushi Ogata [Japon] ; Noriko Umegaki ; Ichiro Katayama ; Atsushi Kumanogoh ; Toshio TanakaPsoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.
003478 (2012) Atsushi Ogata [Japon] ; Atsushi Kumanogoh ; Toshio TanakaPathological role of interleukin-6 in psoriatic arthritis.
003548 (2012) Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio TanakaA case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
003806 (2012) Atsushi Ogata [Japon] ; Noriko Umegaki [Japon] ; Ichiro Katayama [Japon] ; Atsushi Kumanogoh [Japon] ; Toshio Tanaka [Japon]Rhumatisme psoriasique chez deux patients en échec de traitement par le tocilizumab
003A38 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
003C88 (2010) Atsushi Kumanogoh [Japon] ; Masato Ogata [Japon]The study of cytokines by Japanese researchers: a historical perspective

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Atsushi Kumanogoh" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Atsushi Kumanogoh" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Atsushi Kumanogoh
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021